2 No-Brainer Healthcare Stocks to Buy Now
The obesity drug market is creating trillion-dollar winners, but you don't have to pay premium prices for exposure. (NYSE: PFE) and Viking Therapeutics (NASDAQ: VKTX) are both relatively inexpensive compared to their opportunities in obesity. One offers a high-yield blue chip that just spent $10 billion entering the space, while the other is a pure-play biotech with late-stage programs in both injectable and oral weight-loss drugs.
Here's why these two healthcare stocks scan as no-brainer buys right now.
Image source: Getty Images.
Source Fool.com
Pfizer Inc. Aktie
22,50 €
2,32 %
Die Pfizer Inc. Aktie verzeichnet mehrere Buy-Einschätzungen, was auf eine positive Stimmung hindeutet.
Die Community erwartet für Pfizer Inc. ein Kursziel von 27 €, was eine Steigerung von über 20% gegenüber 22.5 € bedeuten würde.
